Complications from stereotactic body radiotherapy for lung cancer KH Kang, CC Okoye, RB Patel, S Siva, T Biswas, RJ Ellis, M Yao, ... Cancers 7 (2), 981-1004, 2015 | 112 | 2015 |
Proton stereotactic radiosurgery for brain metastases: a single-institution analysis of 370 patients KM Atkins, IM Pashtan, MR Bussière, KH Kang, A Niemierko, JE Daly, ... International Journal of Radiation Oncology* Biology* Physics 101 (4), 820-829, 2018 | 46 | 2018 |
Immune checkpoint-mediated myositis and myasthenia gravis: a case report and review of evaluation and management KH Kang, W Grubb, K Sawlani, MK Gibson, CJ Hoimes, LR Rogers, ... American journal of otolaryngology 39 (5), 642-645, 2018 | 35 | 2018 |
Prognostic potential of neutrophil-to-lymphocyte ratio and lymphocyte nadir in stage III non-small-cell lung cancer KH Kang, JT Efird, N Sharma, M Yang, A Dowlati, P Linden, M Machtay, ... Future Oncology 13 (16), 1405-1414, 2017 | 18 | 2017 |
Using the systemic immune-inflammation index (SII) as a mid-treatment marker for survival among patients with stage-III locally advanced non-small cell lung cancer (NSCLC) T Biswas, KH Kang, R Gawdi, D Bajor, M Machtay, C Jindal, JT Efird International journal of environmental research and public health 17 (21), 7995, 2020 | 17 | 2020 |
Proton therapy for head and neck paragangliomas: a single institutional experience KH Kang, ES Lebow, A Niemierko, MR Bussière, NA Dewyer, J Daly, ... Head & neck 42 (4), 670-677, 2020 | 11 | 2020 |
Pretreatment neutrophil-to-lymphocyte ratio as an important prognostic marker in stage III locally advanced non-small cell lung cancer: confirmatory results from the PROCLAIM … T Biswas, R Gawdi, C Jindal, S Iyer, KH Kang, D Bajor, M Machtay, ... Journal of Thoracic Disease 13 (10), 5617, 2021 | 7 | 2021 |
Cost-effectiveness of total neoadjuvant therapy with short-course radiotherapy for resectable locally advanced rectal cancer RI Chin, EE Otegbeye, KH Kang, SH Chang, S McHenry, A Roy, ... JAMA Network Open 5 (2), e2146312-e2146312, 2022 | 4 | 2022 |
The role of proton beam therapy in central neurocytoma: A single-institution experience KH Kang, E Schapira, A Niemierko, M Martinez-Lage, MR Bussière, ... Practical radiation oncology 8 (5), e305-e311, 2018 | 4 | 2018 |
Clinical outcomes of patients with unresectable primary liver cancer treated with MR-guided stereotactic body radiation Therapy: A Six-Year experience RI Chin, JP Schiff, A Bommireddy, KH Kang, N Andruska, AT Price, ... Clinical and Translational Radiation Oncology 41, 100627, 2023 | 3 | 2023 |
Cone beam computed tomography—the need for future guidance JT Efird, C Jindal, TK Podder, KH Kang, T Biswas Journal of Thoracic Disease 14 (10), 3681, 2022 | 3 | 2022 |
In silico trial of simulation-free hippocampal-avoidance whole brain adaptive radiotherapy AT Price, KH Kang, FJ Reynoso, E Laugeman, CD Abraham, J Huang, ... Physics and Imaging in Radiation Oncology 28, 100491, 2023 | 2 | 2023 |
A Pilot Study Examining the Prognostic Utility of Tumor Shrinkage on Cone-Beam Computed Tomography (CBCT) for Stage III Locally Advanced Non-Small Cell Lung Cancer Patients … KH Kang, JT Efird, TK Podder, Y Zhang, A Dowlati, M Machtay, C Jindal, ... International journal of environmental research and public health 18 (6), 3241, 2021 | 2 | 2021 |
Proton radiation therapy for head and neck paragangliomas: A single institution experience KH Kang, E Schapira, A Niemierko, JS Loeffler, HA Shih International Journal of Radiation Oncology, Biology, Physics 99 (2), E346, 2017 | 2 | 2017 |
In-silico trial of simulation-free hippocampal-avoidance whole brain radiotherapy using diagnostic MRI-based and online adaptive planning KH Kang, A Price, FJ Reynoso, E Laugeman, CD Abraham, J Huang, ... International Journal of Radiation Oncology, Biology, Physics 114 (3), e535, 2022 | 1 | 2022 |
Utility of MRI Spine In Supratentorial Glioblastoma With Primitive Neuroectodermal Tumor-Like Components (GBM-PNET) J Huang, K Kang International Journal of Radiation Oncology, Biology, Physics 108 (2), E28-E29, 2020 | 1 | 2020 |
Pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios and lymphocyte nadir as predictors for outcome in stage III non-small cell lung cancer KH Kang, N Sharma, JT Effird, M Yang, M Machtay, T Biswas International Journal of Radiation Oncology, Biology, Physics 96 (2), E486, 2016 | 1 | 2016 |
A Pilot Study of Simulation-Free Hippocampal-Avoidance Whole Brain Radiotherapy Using Diagnostic MRI-Based and Online Adaptive Planning KH Kang, AT Price, FJ Reynoso, E Laugeman, ED Morris, PP Samson, ... International Journal of Radiation Oncology* Biology* Physics, 2024 | | 2024 |
A Phase I/II Dose-Escalation Study Evaluating the Safety of 21 Gy, 23 Gy, and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy: An Interim Toxicity Report D Hong, KH Kang, JM Barnes, BC Baumann, RJ Brenneman, Y Huang, ... International Journal of Radiation Oncology, Biology, Physics 117 (2), e392-e393, 2023 | | 2023 |
Patient Selection is Critical When Evaluating Candidates for 5-Fraction Stereotactic MRI-Guided Adaptive Radiotherapy (SMART) for Locally Advanced Pancreatic Cancer DS Lakomy, JP Schiff, A D'Souza, KH Kang, CJ DeSelm, LE Henke, ... International Journal of Radiation Oncology, Biology, Physics 117 (2), e311-e312, 2023 | | 2023 |